BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29116562)

  • 1. Prediction of long-term (> 10 year) cardiovascular outcomes in heart transplant recipients: Value of stress technetium-99m tetrofosmin myocardial perfusion imaging.
    Veenis JF; Boiten HJ; van den Berge JC; Caliskan K; Maat APWM; Valkema R; Constantinescu AA; Manintveld OC; Zijlstra F; van Domburg RT; Schinkel AFL
    J Nucl Cardiol; 2019 Jun; 26(3):845-852. PubMed ID: 29116562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of 14-year cardiovascular outcomes by dobutamine stress
    Roest S; Boiten HJ; van Domburg RT; Valkema R; Schinkel AFL
    J Nucl Cardiol; 2018 Feb; 25(1):63-71. PubMed ID: 27381341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging for the assessment of very long-term outcome in obese patients?
    Korbee RS; Boiten HJ; Ottenhof M; Valkema R; van Domburg RT; Schinkel AF
    J Nucl Cardiol; 2013 Apr; 20(2):227-33. PubMed ID: 23188629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of 8-year cardiovascular outcomes in patients with systemic arterial hypertension: value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging in a high-risk cohort.
    Wai MC; Ottenhof MJ; Boiten HJ; Valkema R; van Domburg RT; Schinkel AF
    J Nucl Cardiol; 2013 Dec; 20(6):1030-40. PubMed ID: 24132813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography.
    Boiten HJ; van der Sijde JN; Ruitinga PR; Valkema R; Geleijnse ML; Sijbrands EJ; van Domburg RT; Schinkel AF
    J Nucl Cardiol; 2012 Oct; 19(5):907-13. PubMed ID: 22875719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imaging.
    Elhendy A; van Domburg RT; Vantrimpont P; Poldermans D; Bax JJ; van Gelder T; Baan CC; Schinkel A; Roelandt JR; Balk AH
    Am J Cardiol; 2002 Apr; 89(8):964-8. PubMed ID: 11950436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eleven-year prognostic value of dobutamine stress (99m)Tc-sestamibi myocardial perfusion imaging in patients with limited exercise capacity.
    Boiten HJ; van Domburg RT; Valkema R; Schinkel AF
    Am J Cardiol; 2015 Apr; 115(7):884-9. PubMed ID: 25661571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events.
    Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Vourvouri EC; Bountioukos M; Rizzello V; Agricola E; Valkema R; Roelandt JR; Poldermans D
    Am J Cardiol; 2003 Feb; 91(4):408-11. PubMed ID: 12586253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of 99mTc-tetrofosmin SPECT myocardial perfusion imaging on the prediction of future adverse cardiac events.
    Jain D; Lessig H; Patel R; Sandler L; Weiland F; Edell SL; Elizabeth Oates M; O'Malley-Tysko E; Khutoryansky N; Jacobson AF
    J Nucl Cardiol; 2009; 16(4):540-8. PubMed ID: 19396504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of stress Tc-99m tetrofosmin myocardial perfusion imaging in patients with left ventricular hypertrophy.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Feringa HH; Noordzij PG; Schouten O; Poldermans D
    J Nucl Cardiol; 2007 Jul; 14(4):550-4. PubMed ID: 17679064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of dobutamine-atropine stress (99m)Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease.
    Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Roelandt JR; Poldermans D
    J Nucl Med; 2002 Jun; 43(6):767-72. PubMed ID: 12050321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing.
    Schinkel AF; Elhendy A; Biagini E; van Domburg RT; Valkema R; Rizello V; Pedone C; Simoons M; Bax JJ; Poldermans D
    J Nucl Med; 2005 Jan; 46(1):12-8. PubMed ID: 15632027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac stress imaging for the prediction of very long-term outcomes: Dobutamine stress echocardiography or dobutamine
    Boiten HJ; van Domburg RT; Geleijnse ML; Valkema R; Zijlstra F; Schinkel AFL
    J Nucl Cardiol; 2018 Apr; 25(2):471-479. PubMed ID: 27444501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of exercise stress technetium-99m-tetrofosmin myocardial perfusion imaging in patients with normal baseline electrocardiograms.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Huurman A; Feringa HH; Poldermans D
    Am J Cardiol; 2006 Sep; 98(5):585-90. PubMed ID: 16923441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis.
    Elhendy A; Sozzi FB; van Domburg RT; Vantrimpont P; Valkema R; Krenning EP; Roelandt JR; Maat LP; Balk AH
    J Heart Lung Transplant; 2000 Apr; 19(4):360-6. PubMed ID: 10775817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.
    Shanoudy H; Raggi P; Beller GA; Soliman A; Ammermann EG; Kastner RJ; Watson DD
    J Am Coll Cardiol; 1998 Feb; 31(2):331-7. PubMed ID: 9462576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Poldermans D
    J Nucl Cardiol; 2003; 10(6):615-22. PubMed ID: 14668773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of 14-year outcomes in patients with a limited exercise capacity: Utility of dobutamine myocardial perfusion imaging in a high-risk population.
    Veenis JF; Valkema R; van Domburg RT; Schinkel AF
    J Nucl Cardiol; 2015 Oct; 22(5):888-900. PubMed ID: 25537614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging.
    Elhendy A; Schinkel AF; Van Domburg RT; Bax JJ; Poldermans D
    J Hypertens; 2003 Oct; 21(10):1945-51. PubMed ID: 14508202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of dobutamine thallium-201 single-photon emission computed tomography after heart transplantation.
    Wu YW; Yen RF; Lee CM; Ho YL; Chou NK; Wang SS; Huang PJ
    J Heart Lung Transplant; 2005 May; 24(5):544-50. PubMed ID: 15896751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.